
The ancient Chinese text of the Zhuangzi teaches us to reject entrenched values – and treasure the diversity of humanity
Why would the authors of this text, men of privilege, be interested in people who were considered at the time to be 'less than normal'?
The answer relates, at least in part, to the fact that the text was critical of how its society promoted and prioritised the 'valuable' or 'useful', and what was regarded as important to humanity.
Within such a society, whatever – or whoever – falls short of the accepted standards is seen in demeaning ways. But the Zhuangzi rejects this way of thinking.
So how might we put some of these ideas into practice today?
The Zhuangzi tells the story of a wondrous tree, so large that its canopy provided shade for thousands of oxen. The tree only became this large because its wood was deemed to be 'useless' for any human project. Therefore, it was left alone and allowed to grow into its magnificent size.
This story shows how easy it is for us to adopt entrenched values. Are we guided too much by what society tells us is 'useless'? It allows us to turn the tables on our own assumptions and challenge our thinking of what 'normal' and 'useful' means. This is reflective of Daoism more broadly, which advocates for diversity in how we think about humanity and human achievements.
Daoism resists what would today be considered an ableist approach to life. It teaches us that looking at life through an ableist lens only leads to negativity about those who are deemed 'not good enough'. Such an approach looks for how people are deficient, rather than how they are capable.
The Zhuangzi's point is not that we cannot celebrate excellence. Rather, it champions the richness of life by showing that people can be excellent in many different ways. Instead of telling us how to fix people's medical and physiological conditions, it prompts us to reflect on the shallow attitudes of those who see others as 'disabled', who want to draw attention to what some people lack, rather than what they might have.
There isn't a word in the Zhuangzi that means 'disability'. Rather, the ancient text uses storytelling and exaggerated language to try to show how society sees some people in derogatory ways. Stories about 'sad horsehead humpback' or 'hunchback limpleg' show that these are not labels that the men were born with; they were given to them by a society that wrongly prides itself on 'normalising' able-bodied people.
Through these stories, we learn that sometimes the word 'disability' is used unfairly to define people, so that our interactions with them are determined by the label.
As the Zhuangzhi shows, life is too important for us to take a one-size-fits-all approach to it. The philosophy encourages us to embrace the richness of life by appreciating its diversity.
Karyn Lai is a professor of philosophy in the faculty of arts, design and architecture, University of New South Wales
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
3 hours ago
- Daily Mail
CHRISTOPHER STEVENS reviews last night's TV: Astonishing reason 4,000 Japanese kamikaze pilots were picked to die during the Second World War
Kamikaze: An Untold History (BBC4) How much do you want to die for your country? Please tick the applicable box: 'Strongly desire', 'Desire', or 'Negative', and hand your application form to the admin officer. Astonishing almost beyond belief, this was the question posed to Japanese air force pilots during World War II, as revealed in Kamikaze: An Untold History. Slightly less surprising, since armies are the same the world over, their answers were largely ignored as officials selected the fliers who would attempt to crash their planes into Allied aircraft carriers and other ships. Instead, kamikaze pilots were chosen according to their exam results. Those with the highest marks were excused suicide duties, since their intellect made them too valuable. The ones with the lowest scores were also not picked, because they had not earned the right to sacrifice themselves. But nearly 4,000 Japanese men, average age 21 and four months, did fly kamikaze missions between October 1944 and August 1945. This grimly fascinating documentary tried to explain the mentality, not only of the pilots who flew to certain death, but of the nation that encouraged them to do it. As Japanese newsreels showed the pilots sharing a solemn ceremonial drink — lemonade, since they had sworn off alcohol — and radio announcers read out the young men's wills, a cult of kamikaze gripped the country. Their self-immolation became a symbol of what was expected from every citizen, and the slogan '100 million kamikaze' was a national catchphrase. The pilots were known as 'war gods' and 'mighty eagles'. 'Your divine battle will be known for eternity,' declared the newsreader on one piece of archive footage. Workers wore white bandanas in their honour. It seems incomprehensible, until we realise that many of the young men didn't want to die at all. They simply felt they had no choice. One man who wasn't picked said he saw a comrade receive his orders to 'volunteer' with horror: 'My parents didn't send me to university to die,' the doomed man howled. Another survivor, Hijikata Toshio, bravely marked his questionnaire 'negative'. He was engaged to be married, and his ambition was to be a maths teacher, he said. 'Taking a bullet from an enemy is one thing but blowing myself up didn't seem right.' Most of the veterans, filmed over several years, were in their 90s. One, an American sailor named Seth Irving who described waves of kamikaze planes divebombing his fleet, was 103. By the end of the war, so many Japanese aircraft had been destroyed that the pilots were sent out in trainer biplanes with explosives strapped to their fuselage. Slow and cumbersome, they were easily shot down. Survival had become a matter of chance. One pilot, Arai Toshio, played rock-paper-scissors with a fellow flier, for the right to die in their last remaining plane. He lost . . . and lived to be 99.


The Sun
5 hours ago
- The Sun
Three in 5 cases of ‘most challenging cancer to treat' could be prevented, scientists say – how to slash your risk today
THE number of cases of the "most challenging cancer to treat" are set to double by 2050, academics have said. But three in five cases are due to preventable risk factors, they add. 4 Liver cancer is a major cause of death and disability. Globally, it's the sixth most common cancer and the third leading cause of death from cancer. And it's considered one of the most challenging cancers to treat due to late diagnosis, the liver's complex anatomy, and the aggressiveness of the disease. Analyses predicts the number of new liver cancer cases will nearly double from 870,000 in 2022 to 1.52 million in 2050, primarily due to population growth and ageing populations. However, a new analysis as part of The Lancet Commission on liver cancer suggests the majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called non-alcoholic fatty liver disease. Chair of the Commission, Prof Jian Zhou, Fudan University, China, said: 'Liver cancer is a growing health issue around the world. "It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5 per cent to 30 per cent. "We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend.' First author, Prof Stephen Chan, Chinese University of Hong Kong, Hong Kong, China, added: 'As three in five cases of liver cancer are linked to preventable risk factors, mostly viral hepatitis, alcohol and obesity, there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer and save lives.' Liver cancer was previously thought to occur mainly in patients with viral hepatitis or alcohol-related liver disease. Today, rising rates of obesity are an increasing risk factor, mainly due to the increase in cases of excess fat around the liver. MASLD MASLD is primarily caused by the buildup of fat in the liver, a condition often linked to metabolic risk factors such as obesity, type 2 diabetes, and high cholesterol. Approximately a third of the global population are estimated to have it. But only 20 to 30 per cent of patients with MASLD develop the more severe form of the condition with liver inflammation and damage - called metabolic dysfunction-associated steatohepatitis (MASH). The rate of MASLD-linked liver cancer is expected to rise over the next decade, particularly in the USA, Europe, and Asia, due to increasing rates of obesity. In the USA, MASLD prevalence continues to climb in parallel with the obesity epidemic; by 2040, over 55 per cent of US adults could have MASLD. Commission author, Prof Hashem B El-Serag, Baylor College of Medicine, USA, said: "One approach to identify patients at high risk of liver cancer would be to introduce screening for liver damage into routine healthcare practice for patients at high risk of MASLD, such as individuals living with obesity, diabetes, and cardiovascular disease. "Healthcare professionals should also integrate lifestyle counselling into routine care to support patients to transition to a healthy diet and regular physical activity. "Furthermore, policy makers must promote healthy food environments via policies such as sugar taxes and clear labelling on products with high fat, salt, and/or sugar.' Commenting on the study, Pamela Healy, chief executive of the British Liver Trust, said: "Liver cancer is the fastest rising cause of cancer death in the UK, and just 13 per cent of people diagnosed will survive for five years or more. "We know that the biggest risk factors are having pre-existing liver cirrhosis or viral hepatitis, and this new analysis highlights that MASLD, also known as fatty liver disease, is expected to be linked to an increasing number of cases. "As well as improving early detection through surveillance of people with cirrhosis, it is essential that we tackle these underlying causes and prioritise public health. "By supporting people to maintain a healthy weight, cut down on alcohol and get tested and treated for hepatitis, we can prevent many cases of liver cancer and save lives." How to reduce the risk of obesity 4 Adopting healthy lifestyle habits, including balanced nutrition and regular physical activity can help prevent obesity. Focus on whole, unprocessed foods, control portion sizes, and reduce intake of sugary drinks and processed foods. Also, aim for at least 150 minutes of moderate-intensity activity per week, or 75 minutes of vigorous activity. Getting enough sleep and managing stress can also help. How to cut down on alcohol If you regularly drink more than 14 units of alcohol a week, the NHS recommends some simple tips to help you cut down. These include making a plan before you start drinking - set a limit on how much you're going to drink. Letting friends and family know you're cutting down so you can get support from them. And going for smaller-sized drinks and alcohol with a lower strength (ABV in %). How to prevent viral hepatitis 4 To prevent viral hepatitis, focus on vaccination for hepatitis A and B, practising safe sex, and avoiding contact with infected blood. Vaccines for hepatitis A and B are available and highly effective. There isn't a vaccine for hepatitis C, so prevention relies on other measures. Use condoms consistently and correctly to prevent the transmission of hepatitis B and C through sexual contact. Avoid sharing needles and other injection equipment, and ensure proper sanitation and hygiene practices, particularly when travelling to areas with higher risk of hepatitis A and E. Being aware of the symptoms of liver cancer, should they arise, may also help you get treated quicker... LIVER CANCER: THE RISKS AND SYMPTOMS LIVER cancer is one of only a few common types of tumour that have increasing death rates. Experts say unhealthy living, including obesity, drinking alcohol and smoking are fuelling a rise in cases and deaths from the disease. What increases the risk of liver cancer? What are the most common symptoms? Jaundice – your skin and whites of your eyes turn yellow Darker wee and/or paler poo than usual Itchy skin Loss of appetite and/or feeling sick Unexplained weight loss Feeling tired or low on energy all the time A lump in the right side of your tummy


The Guardian
5 hours ago
- The Guardian
Lifestyle changes and vaccination ‘could prevent most liver cancer cases'
Three in five liver cancer cases globally could be prevented by reducing obesity and alcohol consumption and increasing uptake of the hepatitis vaccine, a study has found. The Lancet Commission on liver cancer found that most cases were preventable if alcohol consumption, fatty liver disease and levels of viral hepatitis B and C were reduced. The commission set out several recommendations for policymakers, which it estimated could reduce the incidence of liver cancer cases by 2% to 5% each year by 2050, preventing 9m to 17m new cases of liver cancer and saving 8 million to 15 million lives. Prof Jian Zhou at Fudan University in China, who led the research, said: 'Liver cancer is a growing health issue around the world. It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5% to 30%. We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend.' Liver cancer is the sixth most common cancer worldwide and the third leading cause of cancer death. The number of deaths is predicted to grow from 760,000 in 2022 to 1.37 million in 2050. Previous analyses have predicted that the number of new liver cancer cases will nearly double from 870,000 in 2022 to 1.52m in 2050, mostly due to population growth and ageing populations, with the largest increases expected in Africa. At present, more than 40% of the global liver cancer cases occur in China due to its relatively high rates of hepatitis B infections. One of the fastest growing causes of liver cancer globally is fatty liver disease, and this is expected to rise because of increasing rates of obesity. One-third of the global population is estimated to have metabolic dysfunction-associated steatotic liver disease (MASLD) – previously known as non-alcoholic fatty liver disease, where fat builds up in a person's liver – though it can be prevented by eating a balanced diet, being physically active and potentially losing weight. Only 20% to 30% of people with MASLD go on to develop the more severe form, metabolic dysfunction-associated steatohepatitis (MASH), which can lead to liver cancer. The commission said the proportion of liver cancer cases associated with MASH was projected to increase from 8% in 2022 to 11% in 2050. The second fastest growing cause is alcohol, with associated liver cases projected to increase from 19% in 2022 to 21% in 2050. In contrast, the proportion of liver cancer cases linked to hepatitis B is expected to decrease from 39% in 2022 to 37% in 2050, while hepatitis C-related cases are projected to drop from 29% to 26%. The commission author Prof Hashem B El-Serag of Baylor College of Medicine in the US said: 'Liver cancer was once thought to occur mainly in patients with viral hepatitis or alcohol-related liver disease. However, today, rising rates of obesity are an increasing risk factor for liver cancer, primarily due to the increase in cases of excess fat around the liver.' The commission's recommendations included that governments boost HBV vaccination and implement universal screening for adults; introduce minimum alcohol unit pricing and sugar taxes along with warning labels; invest in early detection of liver damage and cancer; and improve palliative care for sufferers. The commission author Prof Valérie Paradis of Beaujon hospital in France said: 'There is an urgent need to raise awareness within society about the severity of the growing health issue of rising liver cancer cases. 'Compared with other cancers, liver cancer is very hard to treat but has more distinct risk factors, which help define specific prevention strategies. With joint and continuous efforts, we believe many liver cancer cases can be prevented, and both the survival and quality of patients with liver cancer will be considerably improved.' Dr Matt Hoare, an associate professor in hepatology at the University of Cambridge's Early Cancer Institute, said liver cancer was 'unlike many other cancers' in that the death rate was still rising, with the causes varying by region. He said public health policy changes have proven effective, since Japan had successfully reduced its death rate by implementing preventive policies and improving detection to find cancers earlier. His team is seeking to identify new ways to spot patients with liver disease who will develop cancer through DNA sequencing of the liver.